Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders Meeting Abstract

  

Authors:	Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; Ye, J.; Jahn, J.; Pardo, G.; Cabuhat, L.; Notti, R.; Pardo, A.; Affer, M.; Yung, S.; Luliano, J.; Powers, J.; Robbins, D. W.; Nawaratne, V.; Totiger, T. M.; Pena-Velasquez, C.; Rhodes, J. M.; Zelenetz, A. D.; Roeker, L. E.; Lu, H.; Linley, A.; Mato, A. R.; Abdel-Wahab, O.; Taylor, J.
Abstract Title:	Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders
Meeting Title:	64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	140
Issue:	Suppl. 1
Meeting Dates:	2022 Dec 10-13
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2022-11-15
Start Page:	1811
End Page:	1813
Language:	English
ACCESSION:	WOS:000893223201336
DOI:	10.1182/blood-2022-163268
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/205006